Select Publications
Journal articles
2020, 'Declining HCV incidence following rapid HCV treatment scale-up in a prison network in Australia: Evidence of treatment as prevention from the SToP-C study', JOURNAL OF HEPATOLOGY, 73, pp. S127 - S127, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000786587000206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Is parent engagement with a child health home-based record associated with parents perceived attitude towards health professionals and satisfaction with the record? A cross-sectional survey of parents in New South Wales, Australia', International Journal of Environmental Research and Public Health, 17, pp. 1 - 11, http://dx.doi.org/10.3390/ijerph17155520
,2020, 'Opportunities to enhance linkage to hepatitis C care among people hospitalised for injection drug use-related complications: a population-based study', JOURNAL OF HEPATOLOGY, 73, pp. S807 - S808, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000786587002392&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Factors Associated with Early Resumption of Condomless Anal Sex among Men Who Have Sex with Men after Rectal Chlamydia Treatment', Sexually Transmitted Diseases, 47, pp. 389 - 394, http://dx.doi.org/10.1097/olq.0000000000001166
,2020, 'Patterns of drug and alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis c virus treatment with directacting antiviral therapies: An international study', Clinical Infectious Diseases, 70, pp. 2369 - 2376, http://dx.doi.org/10.1093/cid/ciz633
,2020, 'Is parent engagement with a child health home-based record influenced by early child development and first-born status? hypotheses from a high-income countries’ perspective', Medical Hypotheses, 137, http://dx.doi.org/10.1016/j.mehy.2020.109605
,2020, 'Monitoring health and well-being in emerging adults: Protocol for a pilot longitudinal cohort study', JMIR Research Protocols, 9, http://dx.doi.org/10.2196/16108
,2019, 'Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia', Journal of Hepatology, 71, pp. 281 - 288, http://dx.doi.org/10.1016/j.jhep.2019.04.014
,2019, 'Incidence and time trends of anal cancer among people living with HIV in Australia', AIDS, 33, pp. 1361 - 1368, http://dx.doi.org/10.1097/QAD.0000000000002218
,2019, 'Are parent-held child health records a valuable health intervention? A systematic review and meta-analysis', International Journal of Environmental Research and Public Health, 16, http://dx.doi.org/10.3390/ijerph16020220
,2019, 'SAT-232-Reinfection following successful HCV DAA therapy among people with recent injecting drug use', Journal of Hepatology, 70, pp. e732 - e733, http://dx.doi.org/10.1016/s0618-8278(19)31465-3
,2018, 'Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study', International Journal of Drug Policy, 62, pp. 14 - 23, http://dx.doi.org/10.1016/j.drugpo.2018.08.013
,2018, 'Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study', The Lancet HIV, 5, pp. e629 - e637, http://dx.doi.org/10.1016/S2352-3018(18)30215-7
,2018, 'Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection.', J Infect Dis, 218, pp. 1383 - 1393, http://dx.doi.org/10.1093/infdis/jiy328
,2018, 'Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot Samples', Journal of Molecular Diagnostics, 20, pp. 621 - 627, http://dx.doi.org/10.1016/j.jmoldx.2018.05.010
,2018, 'Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay', Journal of Infectious Diseases, 217, pp. 1889 - 1896, http://dx.doi.org/10.1093/infdis/jiy114
,2018, 'Mortality trends among people with hepatitis B and C: A population-based linkage study, 1993-2012', BMC Infectious Diseases, 18, http://dx.doi.org/10.1186/s12879-018-3110-0
,2018, 'Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study', Journal of Viral Hepatitis, 25, pp. 473 - 481, http://dx.doi.org/10.1111/jvh.12837
,2018, 'Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study', International Journal of Drug Policy, 54, pp. 18 - 25, http://dx.doi.org/10.1016/j.drugpo.2017.12.013
,2018, 'Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy (vol 32, pg 357, 2018)', AIDS, 32, pp. 683 - 683, http://dx.doi.org/10.1097/01.aids.0000530853.88590.a9
,2018, 'Reply to: “Direct antiviral agents and risk of HCC: Waiting for Godot”', Journal of Hepatology, 68, pp. 616 - 617, http://dx.doi.org/10.1016/j.jhep.2017.10.002
,2018, 'Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial', The Lancet Gastroenterology and Hepatology, 3, pp. 153 - 161, http://dx.doi.org/10.1016/S2468-1253(17)30404-1
,2018, 'The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study', Journal of Hepatology, 68, pp. 393 - 401, http://dx.doi.org/10.1016/j.jhep.2017.10.019
,2018, 'Erratum: Correction: expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in new South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial (BMC public health (2018) 18 1 (210))', BMC public health, 18, pp. 297, http://dx.doi.org/10.1186/s12889-018-5173-7
,2018, 'Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): Design of an open label, single arm implementation trial', BMC Public Health, 18, pp. 210, http://dx.doi.org/10.1186/s12889-017-5018-9
,2018, 'Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy', AIDS, 32, pp. 357 - 361, http://dx.doi.org/10.1097/QAD.0000000000001688
,2018, 'Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study', HIV Medicine, 19, pp. 65 - 71, http://dx.doi.org/10.1111/hiv.12532
,2017, 'Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression', Journal of Hepatology, 67, pp. 1204 - 1212, http://dx.doi.org/10.1016/j.jhep.2017.07.025
,2017, 'Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study', International Journal of Drug Policy, 47, pp. 230 - 238, http://dx.doi.org/10.1016/j.drugpo.2017.05.040
,2017, 'Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study', International Journal of Drug Policy, 47, pp. 177 - 186, http://dx.doi.org/10.1016/j.drugpo.2017.05.020
,2017, 'HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV', Journal of Virology, 91, pp. e00700 - e00717, http://dx.doi.org/10.1128/JVI.00700-17
,2017, 'Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study', Journal of Viral Hepatitis, 24, pp. 733 - 741, http://dx.doi.org/10.1111/jvh.12701
,2017, 'Anti-HIV-1 ADCC antibodies following latency reversal and treatment interruption', Journal of Virology, 91, pp. e00603 - e00617, http://dx.doi.org/10.1128/JVI.00603-17
,2017, 'Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts', Journal of Acquired Immune Deficiency Syndromes, 75, pp. 345 - 353, http://dx.doi.org/10.1097/qai.0000000000001380
,2017, 'Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study', The Lancet Gastroenterology and Hepatology, 2, pp. 514 - 520, http://dx.doi.org/10.1016/S2468-1253(17)30075-4
,2017, 'Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study', BMC Infectious Diseases, 17, pp. 420, http://dx.doi.org/10.1186/s12879-017-2517-3
,2017, 'Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis', HIV Medicine, 18, pp. 256 - 266, http://dx.doi.org/10.1111/hiv.12421
,2017, 'Treatment efficacy of azithromycin 1 g single dose versus doxycycline 100 mg twice daily for 7 days for the treatment of rectal chlamydia among men who have sex with men - a double-blind randomised controlled trial protocol', BMC Infectious Diseases, 17, pp. 35, http://dx.doi.org/10.1186/s12879-016-2125-7
,2017, 'Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study', The Lancet HIV, 4, pp. e13 - e20, http://dx.doi.org/10.1016/S2352-3018(16)30189-8
,2017, 'Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment', Journal of Gastroenterology and Hepatology (Australia), 32, pp. 229 - 236, http://dx.doi.org/10.1111/jgh.13453
,2017, 'Comparison of dried blood spots versus conventional plasma collection for the characterization of efavirenz pharmacokinetics in a large-scale global clinical trial-the ENCORE1 study', Therapeutic Drug Monitoring, 39, pp. 654 - 658, http://dx.doi.org/10.1097/FTD.0000000000000448
,2017, 'Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014)', Hepatology Communications, 1, pp. 736 - 747, http://dx.doi.org/10.1002/hep4.1073
,2017, '13 HIV-1-specific ADCC following anti-latency therapy and analytical treatment interruption', Journal of Virus Eradication, 3, pp. 10 - 10, http://dx.doi.org/10.1016/s2055-6640(20)30718-4
,2017, 'O23 Characterisation of populations with hepatitis C to improve access to antiviral therapy programs: a population-based linkage study', Journal of Virus Eradication, 3, pp. 9 - 9, http://dx.doi.org/10.1016/s2055-6640(20)30906-7
,2017, 'O6 Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the StoP-C study', Journal of Virus Eradication, 3, pp. 2 - 3, http://dx.doi.org/10.1016/s2055-6640(20)30889-x
,2017, 'P10 Injecting risk behaviours among people who inject drugs in an Australian prison setting, 2005–2014: the HITS-p study', Journal of Virus Eradication, 3, pp. 15 - 16, http://dx.doi.org/10.1016/s2055-6640(20)30751-2
,2016, 'Hospitalization for anxiety and mood disorders in HIV-infected and -uninfected gay and bisexual men', Journal of Acquired Immune Deficiency Syndromes, 73, pp. 589 - 597, http://dx.doi.org/10.1097/QAI.0000000000001147
,2016, 'Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual Men.', J Acquir Immune Defic Syndr, 73, pp. 589 - 597, http://dx.doi.org/10.1097/QAI.0000000000001147
,2016, 'Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000–2014)', Journal of Hepatology, 65, pp. 1086 - 1093, http://dx.doi.org/10.1016/j.jhep.2016.08.010
,2016, 'Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based study', Journal of Hepatology, 65, pp. 879 - 887, http://dx.doi.org/10.1016/j.jhep.2016.06.025
,